Gilead™Solutions is a comprehensive set of programs designed to help you navigate the reimbursement process and assist those without adequate financial resources identify alternate means of support for access to Letairis® (ambrisentan).
Patient Assistance Solutions
This program is for patients who neither have nor qualify for public or private insurance. It is available for patients who meet certain eligibility criteria. The Letairis® Education and Access Program (LEAP) will help you find out if you qualify for public or private programs for prescription drug coverage. If you do not qualify, LEAP will assist you in applying to receive therapy free of charge through this program.
This program can help reduce the cost of treatment if you have private insurance. This program works to limit your out-of-pocket expenses to $25 per month. If you are eligible, Gilead may be able to provide assistance up to $9,200 per year towards the cost of your therapy. To qualify for this program, you may be asked to provide additional information on your health insurance plan.
This program provides financial support to individuals with chronic conditions who are on a public health insurance program such as Medicare or Medicaid, and those who have private insurance but are facing financial challenges or are at risk of losing private insurance. Individual eligibility and level of support are determined by non-profit foundations.
Who is Eligible?
All programs require periodic re-enrollment to confirm eligibility, and patients will be notified when re-enrollment is necessary.
You must be enrolled in LEAP to receive Letairis® therapy and to receive financial assistance through one or more of the Gilead™Solutions programs.
LEAP will investigate your program eligibility and will work with you to submit supplemental applications for each of the programs, along with any necessary supporting documentation.
How Do I Apply?
To find out if you are eligible for one or more Gilead™Solutions programs, call 1-866-664-LEAP (1-866-664-5327).
Find out more information about Letairis® (ambrisentan)